{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:30:57Z","timestamp":1774020657793,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA260137\\u201301A1"],"award-info":[{"award-number":["R01 CA260137\\u201301A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.mcb.2024.11.001","type":"book-chapter","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T12:21:34Z","timestamp":1734178894000},"source":"Crossref","is-referenced-by-count":1,"title":["Establishing Tyro3, Axl, and Mertk Chinese hamster ovary (CHO) reporter cell lines for cancer immunology and therapeutic applications"],"prefix":"10.1016","author":[{"given":"Ahmed","family":"Aquib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Gadiyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Pulica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Varsanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-I.","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley\u00a0G.","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Smirnov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana S.","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei V.","family":"Kotenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond B.","family":"Birge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.mcb.2024.11.001_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ni871","article-title":"Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells","volume":"4","author":"Anderson","year":"2003","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.neuron.2012.10.015","article-title":"Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis","volume":"76","author":"Burstyn-Cohen","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/bs.mcb.2024.11.001_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2012.07.009","article-title":"Tubby regulates microglial phagocytosis through MerTK","volume":"252","author":"Caberoy","year":"2012","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib4","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1038\/emboj.2010.265","article-title":"Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis","volume":"29","author":"Caberoy","year":"2010","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.mcb.2024.11.001_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1172\/JCI90520","article-title":"MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis","volume":"127","author":"Cai","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.mcb.2024.11.001_bib6","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/sj.onc.1201039","article-title":"Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation","volume":"14","author":"Chen","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/bs.mcb.2024.11.001_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8120107","article-title":"Ligand activation of TAM family receptors-implications for tumor biology and therapeutic response","volume":"8","author":"Davra","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.mcb.2024.11.001_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1158\/0008-5472.CAN-20-2066","article-title":"Axl and mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host antitumor immunity","volume":"81","author":"Davra","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2024.11.001_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature17630","article-title":"TAM receptors regulate multiple features of microglial physiology","volume":"532","author":"Fourgeaud","year":"2016","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2024.11.001_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102207","article-title":"Cell death in the tumor microenvironment: Implications for cancer immunotherapy","volume":"9","author":"Gadiyar","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.mcb.2024.11.001_bib11","doi-asserted-by":"crossref","first-page":"1135373","DOI":"10.3389\/fimmu.2023.1135373","article-title":"Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders","volume":"14","author":"Gadiyar","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.gene.6363714","article-title":"Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10)","volume":"1","author":"Gallagher","year":"2000","journal-title":"Genes and Immunity"},{"key":"10.1016\/bs.mcb.2024.11.001_bib13","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3389\/fimmu.2017.01521","article-title":"Requirement of gamma-carboxyglutamic acid modification and phosphatidylserine binding for the activation of Tyro3, Axl, and Mertk receptors by growth arrest-specific 6","volume":"8","author":"Geng","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrc3847","article-title":"The TAM family: Phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer","volume":"14","author":"Graham","year":"2014","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.mcb.2024.11.001_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/imr.13259","article-title":"Hijacking homeostasis: Regulation of the tumor microenvironment by apoptosis","volume":"319","author":"Gregory","year":"2023","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.mcb.2024.11.001_bib16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s42003-023-05287-y","article-title":"Regulation of brain endothelial cell physiology by the TAM receptor tyrosine kinase Mer","volume":"6","author":"Happonen","year":"2023","journal-title":"Communications Biology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107577","article-title":"MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system","volume":"213","author":"Huelse","year":"2020","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.mcb.2024.11.001_bib18","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0021-9258(17)42103-X","article-title":"The proto-oncogene of v-eyk (v-ryk) is a novel receptor-type protein tyrosine kinase with extracellular Ig\/GN-III domains","volume":"269","author":"Jia","year":"1994","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2024.11.001_bib19","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1158\/0008-5472.CAN-18-2614","article-title":"Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer","volume":"79","author":"Kasikara","year":"2019","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2024.11.001_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1158\/1541-7786.MCR-16-0350","article-title":"Phosphatidylserine sensing by TAM receptors regulates AKT-dependent chemoresistance and PD-L1 expression","volume":"15","author":"Kasikara","year":"2017","journal-title":"Molecular Cancer Research: MCR"},{"key":"10.1016\/bs.mcb.2024.11.001_bib21","doi-asserted-by":"crossref","first-page":"43908","DOI":"10.1038\/srep43908","article-title":"Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity","volume":"7","author":"Kimani","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.mcb.2024.11.001_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12964-016-0142-1","article-title":"Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase","volume":"14","author":"Kimani","year":"2016","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10.1016\/bs.mcb.2024.11.001_bib23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/hed.27340","article-title":"Dual Axl\/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer","volume":"45","author":"Kostecki","year":"2023","journal-title":"Head & Neck"},{"key":"10.1016\/bs.mcb.2024.11.001_bib24","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.4049\/jimmunol.166.12.7096","article-title":"Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity","volume":"166","author":"Kotenko","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib25","doi-asserted-by":"crossref","first-page":"22995","DOI":"10.1074\/jbc.M909607199","article-title":"Signaling by covalent heterodimers of interferon-gamma. Evidence for one-sided signaling in the active tetrameric receptor complex","volume":"275","author":"Krause","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2024.11.001_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/bs.ircmb.2022.04.004","article-title":"Mertk: An emerging target in cancer biology and immuno-oncology","volume":"368","author":"Lahey","year":"2022","journal-title":"International Review of Cell and Molecular Biology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib27","doi-asserted-by":"crossref","first-page":"a009076","DOI":"10.1101\/cshperspect.a009076","article-title":"Biology of the TAM receptors","volume":"5","author":"Lemke","year":"2013","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nri2303","article-title":"Immunobiology of the TAM receptors","volume":"8","author":"Lemke","year":"2008","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.1061663","article-title":"Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family","volume":"293","author":"Lu","year":"2001","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.mcb.2024.11.001_bib30","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/cvr\/cvz100","article-title":"TAM receptors in cardiovascular disease","volume":"115","author":"McShane","year":"2019","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.mcb.2024.11.001_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mcn.2006.06.011","article-title":"TAM receptor function in the retinal pigment epithelium","volume":"33","author":"Prasad","year":"2006","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/bs.mcb.2024.11.001_bib32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM receptors are pleiotropic inhibitors of the innate immune response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2024.11.001_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.emboj.7600912","article-title":"Structural basis for Gas6-Axl signalling","volume":"25","author":"Sasaki","year":"2006","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.mcb.2024.11.001_bib34","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1172\/JCI76375","article-title":"Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution","volume":"124","author":"Stanford","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.mcb.2024.11.001_bib35","doi-asserted-by":"crossref","first-page":"25750","DOI":"10.1074\/jbc.M114.569020","article-title":"Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation","volume":"289","author":"Tsou","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2024.11.001_bib36","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni.2986","article-title":"Diversification of TAM receptor tyrosine kinase function","volume":"15","author":"Zagorska","year":"2014","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.mcb.2024.11.001_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2020.01.014","article-title":"Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP","volume":"52","author":"Zhou","year":"2020","journal-title":"Immunity"}],"container-title":["Methods in Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X24002383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X24002383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T06:57:58Z","timestamp":1750402678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X24002383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2024.11.001","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}